liraglutide vs semaglutide vs tirzepatide and for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States Orderly Meds Review: 30-Day Trial,

Effects of the soluble guanylate cyclase stimulator praliciguat in diabetic kidney disease a randomized placebo-controlled clinical trial

Practice parameters for the indications for polysomnography and related procedures: an update for 2005

In people with type 2 diabetes who also use insulin or insulin-stimulating drugs, such as sulfonylureas, the risk of low blood sugar, also called hypoglycemia, may be increased, so the doses of those medicines may need to be lowered

[DOI] [PMC free article] [PubMed] [Google Scholar] 131.De Vincentis A., Mancina R.M., Pihlajamki J., Mnnist V., Petta S., Dongiovanni P., Fracanzani A.L., Valenti L., Tavaglione F., Romeo S., et al

Responses vary from person to person, and Retatrutide is still an investigational compound, so it should only be used under professional supervision